암조직 지향성 수용성 포르피린 유도체, 그 제조방법 및용도
    1.
    发明公开
    암조직 지향성 수용성 포르피린 유도체, 그 제조방법 및용도 无效
    肿瘤靶向水溶性磷吡啶衍生物及其制备方法及其用途

    公开(公告)号:KR1020020090770A

    公开(公告)日:2002-12-05

    申请号:KR1020010029784

    申请日:2001-05-29

    Abstract: PURPOSE: Provided are tumor targeting water soluble porphyrin derivatives which form a complex with other anticancer agents and are thus used for delivering the anticancer agents to tumor tissues, and their preparation method and use, thereby minimizing an ill effect of an anticancer agent and increasing water-solubility. CONSTITUTION: The porphyrin derivative is represented by the formula(2), wherein m is zinc or two of hydrogen ions; Y is 0 or RX; R is selected from alkyl amine or alkylcarboxylate; and X is a halide ion.

    Abstract translation: 目的:提供与其它抗癌剂形成复合物的肿瘤靶向水溶性卟啉衍生物,因此用于将抗癌剂递送至肿瘤组织及其制备方法和用途,从而最小化抗癌剂的不良作用和增加水 -solubility。 构成:卟啉衍生物由式(2)表示,其中m为锌或两个氢离子; Y为0或RX; R选自烷基胺或烷基羧酸盐; X为卤离子。

Patent Agency Ranking